UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 20, 2007
-------------
SUNWIN INTERNATIONAL NEUTRACEUTICALS,INC.
(Exact name of registrant as specified in its charter)
Nevada 033-10456 56-2416925
---------------------------- -------------------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
6 Youpeng Road, Qufu, Shandong, China 273100
--------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (86) 537-4424999
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 REGULATION FD DISCLOSURE
On August 20, 2007, we issued a press release regarding a corporate
update and our business outlook for fiscal year 2008. The press release is
attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information contained in the press release attached hereto is
being furnished and shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liability of that Section, and shall not be incorporated by
reference into any registration statement or other document filed under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing.
Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
99.1 Press Release dated August 20, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.
Date: August 20, 2007 By: /s/ Dongdong Lin
--------------------------
Dongdong Lin
Chief Executive Officer